(0.19%) 5 109.80 points
(0.31%) 38 357 points
(0.25%) 15 967 points
(-1.38%) $82.69
(5.77%) $2.03
(0.16%) $2 350.90
(-0.04%) $27.53
(3.91%) $958.20
(-0.21%) $0.933
(-0.33%) $10.99
(-0.53%) $0.796
(1.67%) $93.41
2 days till quarter result
(bmo 2024-05-01)
Expected move: +/- 6.85%
5.96% $ 2.76
@ $3.65
Ausgestellt: 14 Feb 2024 @ 15:30
Rendite: -24.56%
Vorheriges Signal: Feb 12 - 21:55
Vorheriges Signal:
Rendite: -6.48 %
Live Chart Being Loaded With Signals
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases...
Stats | |
---|---|
Tagesvolumen | 867 126 |
Durchschnittsvolumen | 1.70M |
Marktkapitalisierung | 399.73M |
EPS | $0 ( 2024-02-14 ) |
Nächstes Ertragsdatum | ( $-0.350 ) 2024-05-01 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.770 |
ATR14 | $0.00600 (0.22%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-12 | Neupert Peter M | Buy | 15 000 | Common Stock |
2024-03-12 | Neupert Peter M | Sell | 15 000 | Stock Option (right to buy) |
2024-03-04 | Pellini Michael J | Buy | 31 328 | Common Stock |
2024-03-04 | Pellini Michael J | Buy | 48 044 | Stock Option (right to buy) |
2024-03-04 | Owen Katey Einterz | Buy | 31 328 | Common Stock |
INSIDER POWER |
---|
61.58 |
Last 100 transactions |
Buy: 4 473 782 | Sell: 1 037 795 |
Volumen Korrelation
Adaptive Biotechnologies Korrelation
10 Am meisten positiv korreliert | |
---|---|
MNRO | 0.955 |
TNYA | 0.95 |
OTLY | 0.95 |
GOODM | 0.948 |
RENT | 0.944 |
NGM | 0.943 |
LYT | 0.943 |
NVCR | 0.943 |
SPI | 0.941 |
CTSO | 0.941 |
10 Am meisten negativ korreliert | |
---|---|
SKYA | -0.953 |
HERA | -0.948 |
BRIV | -0.942 |
LDHA | -0.94 |
AGGR | -0.939 |
HERAU | -0.939 |
ISEE | -0.939 |
CRZN | -0.938 |
TBSAU | -0.938 |
PRSR | -0.937 |
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Adaptive Biotechnologies Korrelation - Währung/Rohstoff
Adaptive Biotechnologies Finanzdaten
Annual | 2023 |
Umsatz: | $170.28M |
Bruttogewinn: | $72.49M (42.57 %) |
EPS: | $-1.560 |
FY | 2023 |
Umsatz: | $170.28M |
Bruttogewinn: | $72.49M (42.57 %) |
EPS: | $-1.560 |
FY | 2022 |
Umsatz: | $185.31M |
Bruttogewinn: | $127.40M (68.75 %) |
EPS: | $-1.000 |
FY | 2021 |
Umsatz: | $154.34M |
Bruttogewinn: | $105.04M (68.06 %) |
EPS: | $-1.580 |
Financial Reports:
No articles found.
Adaptive Biotechnologies
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signals; and T-Detect COVID for the confirmation of past COVID-19 infection. It also provides clonoSEQ, a clinical diagnostic product for the detection and monitoring of minimal residual disease in patients with multiple myeloma, B cell acute lymphoblastic leukemia, and chronic lymphocytic leukemia, as well as available as a CLIA-validated laboratory developed test for patients with other lymphoid cancers; and immunoSEQ T-MAP COVID for vaccine developers and researchers to measure the T-cell immune response to vaccines. In addition, the company offers a pipeline of clinical products and services that are used for the diagnosing, monitoring, and treatment of diseases, such as cancer, autoimmune conditions, and infectious diseases. It serves the life sciences research, clinical diagnostics, and drug discovery applications. Adaptive Biotechnologies Corporation has strategic collaborations with Genentech, Inc. for the development, manufacture, and commercialization of neoantigen directed T cell therapies for the treatment of a range of cancers; and Microsoft Corporation to develop diagnostic tests for the early detection of various diseases from a single blood test. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.